(Q74089805)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9442341%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

Plasma 3-methoxy-4-hydroxyphenylglycol and homovanillic acid measurements in deficit and nondeficit forms of schizophrenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9442341%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9442341%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

F Thibaut

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9442341%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

J M Ribeyre

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9442341%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

J F Ménard

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9442341%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

S Dollfus

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9442341%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

M Petit

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9442341%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

publication date

1 January 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9442341%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

published in

Biological Psychiatry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9442341%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9442341%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9442341%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

24-30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9442341%20AND%20SRC:MED&resulttype=core&format=json

Homovanillic acid measurement in clinical research: a review of methodology

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Assessment of the Central Dopaminergic Index of Plasma HVA in Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Central dopamine turnover in schizophrenic syndromes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Sex differences in plasma homovanillic acid in acute psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Noradrenergic and dopaminergic interrelation in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Plasma norepinephrine in chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Clinical correlates of the deficit syndrome of schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Structural abnormalities in deficit and nondeficit schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Deficit and nondeficit forms of schizophrenia: the concept

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Strong inference, theory testing, and the neuroanatomy of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Plasma homovanillic acid as a predictor of response to neuroleptics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Negative symptoms in schizophrenia: their evolution during an acute phase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Differential effect of intrastriatal kainic acid on the modulation of dopamine release by mu- and delta-opioid peptides: a microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Plasma and cerebrospinal fluid 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) as indices of brain norepinephrine metabolism in primates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Testing systems for assessment of negative symptoms in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Free and conjugated plasma homovanillic acid in schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Schizophrenia: instability in norepinephrine, serotonin, and gamma-aminobutyric acid systems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Heterologous regulation of receptors on target cells of dopamine neurons in the prefrontal cortex, nucleus accumbens, and striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Haloperidol response and plasma catecholamines and their metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Measurement of plasma homovanillic acid concentrations in schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

The positive and negative syndrome scale (PANSS) for schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Anhedonia and the deficit syndrome of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

The Schedule for the Deficit syndrome: an instrument for research in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Case identification and stability of the deficit syndrome of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Relation between plasma and cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylglycol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Relationship between urinary excretion of homovanillic acid and norepinephrine metabolites in normal subjects and patients with orthostatic hypotension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Plasma HVA, tardive dyskinesia and psychotic symptoms in long-term drug-free inpatients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Schizophrenic patients with deficit syndrome have higher plasma homovanillic acid concentrations and ventricular enlargement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Behavioral and neurochemical changes in response to acute stressors: influence of previous chronic exposure to immobilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Cerebrospinal Fluid Amine Metabolites in Acute Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

A comparison of plasma homovanillic acid in the deficit and nondeficit subtypes of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Enhanced noradrenergic neuronal activity increases homovanillic acid levels in cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Serum homovanillic acid levels in schizophrenic patients and normal control subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Longitudinal changes in symptoms and plasma homovanillic acid levels in chronically medicated schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Limbic System Abnormalities Identified in Schizophrenia Using Positron Emission Tomography With Fluorodeoxyglucose and Neocortical Alterations With Deficit Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Norepinephrine in acute exacerbations of chronic schizophrenia. Negative symptoms revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

Implications of normal brain development for the pathogenesis of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

The neural basis of the deficit syndrome of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900023-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(97)00023-1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9442341%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference